Mild Cognitive Impairment (MCI) is an early stage of memory loss or other cognitive ability loss in individuals who maintain the ability to independently perform most activities of daily living. It is considered a transitional stage between normal cognitive stage and more severe cognitive declines like dementia or Alzheimer's. Based on the reports from the National Institute of Aging (NIA), people with MCI are at a greater risk of developing dementia, thus it is of great importance to detect MCI at the earliest possible to mitigate the transformation of MCI to Alzheimer's and dementia. Recent studies have harnessed Artificial Intelligence (AI) to develop automated methods to predict and detect MCI. The majority of the existing research is based on unimodal data (e.g., only speech or prosody), but recent studies have shown that multimodality leads to a more accurate prediction of MCI. However, effectively exploiting different modalities is still a big challenge due to the lack of efficient fusion methods. This study proposes a robust fusion architecture utilizing an embedding-level fusion via a co-attention mechanism to leverage multimodal data for MCI prediction. This approach addresses the limitations of early and late fusion methods, which often fail to preserve inter-modal relationships. Our embedding-level fusion aims to capture complementary information across modalities, enhancing predictive accuracy. We used the I-CONECT dataset, where a large number of semi-structured conversations via internet/webcam between participants aged 75+ years old and interviewers were recorded. We introduce a multimodal speech-language-vision Deep Learning-based method to differentiate MCI from Normal Cognition (NC). Our proposed architecture includes co-attention blocks to fuse three different modalities at the embedding level to find the potential interactions between speech (audio), language (transcribed speech), and vision (facial videos) within the cross-Transformer layer. Experimental results demonstrate that our fusion method achieves an average AUC of 85.3% in detecting MCI from NC, significantly outperforming unimodal (60.9%) and bimodal (76.3%) baseline models. This superior performance highlights the effectiveness of our model in capturing and utilizing the complementary information from multiple modalities, offering a more accurate and reliable approach for MCI prediction.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.compbiomed.2024.109199 | DOI Listing |
Mol Genet Genomic Med
February 2025
Department of Pediatric Neurology, Hospital Universitario Quirónsalud, Madrid, Spain.
Background: Biallelic pathogenic variants in the FUCA1 gene are associated with fucosidosis. This report describes a 4-year-old boy presenting with psychomotor regression, spasticity, and dystonic postures.
Methods And Results: Trio-based whole exome sequencing revealed two previously unreported loss-of-function variants in the FUCA1 gene.
Handb Clin Neurol
January 2025
Sleep Medicine Center, Department of Neurology, Villa Serena Hospital, Città S. Angelo, Pescara, Italy; Villaserena Research Foundation, Città S. Angelo, Pescara, Italy.
Advanced sleep phase (ASP) is seldom brought to medical attention because many individuals easily adapt to their early chronotype, especially if it emerges before the age of 30 and is present in a first-degree relative. In this case, the disorder is considered familial (FASP) and is mostly discovered coincidentally in the presence of other sleep disorders, mainly obstructive sleep apnea syndrome (OSAS). The prevalence of FASP is currently estimated to be between 0.
View Article and Find Full Text PDFJ Prev Alzheimers Dis
February 2025
Department of Neurology and National Center for Neurological Disorders, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, PR China. Electronic address:
Background: Cognitive decline and the progression to Alzheimer's disease (AD) are traditionally associated with amyloid-beta (Aβ) and tau pathologies. This study aims to evaluate the relationships between microstructural white matter injury, cognitive decline and AD core biomarkers.
Methods: We conducted a longitudinal study of 566 participants using peak width of skeletonized mean diffusivity (PSMD) to quantify microstructural white matter injury.
J Prev Alzheimers Dis
February 2025
Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China, 154 Anshan Road Tianjin 300052, PR China; Department of Neurology, Tianjin Medical University General Hospital Airport Site, Tianjin 300052, PR China. Electronic address:
Background: Changes in cerebral blood flow (CBF) may contribute to the initial stages of the pathophysiological process in patients with Alzheimer's disease (AD). Hypoperfusion has been observed in several brain regions in patients with mild cognitive impairment (MCI). However, the clinical significance of CBF changes in the early stages of AD is currently unclear.
View Article and Find Full Text PDFJ Prev Alzheimers Dis
February 2025
The ADNI is detailed in Supplemental Acknowledgments.
Background: α-Synuclein (α-Syn) pathology is present in 30-50 % of Alzheimer's disease (AD) patients, and its interactions with tau proteins may further exacerbate pathological changes in AD. However, the specific role of different aggregation forms of α-Syn in the progression of AD remains unclear.
Objectives: To explore the relationship between various aggregation types of CSF α-Syn and Alzheimer's disease progression.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!